YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy

BACKGROUND: YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) has been indicated proven to participate in the cross-presentation of tumor antigens in dendritic cells and the cross-priming of CD8+ T cells. However, the role of YTHDF1 in prognosis and immunology in human cancers remains largely un...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jian, Qiu, Dongxu, Yu, Anze, Hu, Jiao, Deng, Hao, Li, Huihuang, Yi, Zhenglin, Chen, Jinbo, Zu, Xiongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134747/
https://www.ncbi.nlm.nih.gov/pubmed/34026603
http://dx.doi.org/10.3389/fonc.2021.607224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134747/
https://www.ncbi.nlm.nih.gov/pubmed/34026603
http://dx.doi.org/10.3389/fonc.2021.607224

Ejemplares similares